BRTX vs XLK
BioRestorative Therapies Inc (BRTX) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
XLK does not have a complete income-statement cache yet.
BRTX currently screens at market cap $10.2M. XLK currently screens at market cap $0.
Not investment advice. Open the BRTX and XLK stock pages for the full models.
Not investment advice.